Lingxi Kong

14 papers and 321 indexed citations i.

Lingxi Kong has authored 14 papers that have received a total of 321 indexed citations. This includes 5 papers in Epidemiology, 4 papers in Oncology and 4 papers in Cancer Research. The topics of these papers are Liver Disease Diagnosis and Treatment (4 papers), COVID-19 Clinical Research Studies (3 papers) and Long-Term Effects of COVID-19 (3 papers). Lingxi Kong is often cited by papers focused on Liver Disease Diagnosis and Treatment (4 papers), COVID-19 Clinical Research Studies (3 papers) and Long-Term Effects of COVID-19 (3 papers) and collaborates with scholars based in China, Australia and United States. Lingxi Kong's co-authors include Yuanda Zhou, Xuefeng Shan, Hai‐Qiang Wang and Siyuan Chen and has published in prestigious journals such as World Journal of Gastroenterology, Oncotarget and International Immunopharmacology.